Thrombophilia Screening After Severe IUGR

Thrombophilia Screening in Women After Severe IUGR

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05551078

Enrollment

100

Registered

2022-09-22

Start date

2022-09-15

Completion date

2023-01-31

Last updated

2022-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IUGR, Pregnancy Complications, Thrombophilia

Brief summary

This retrospective study aims to assess the input of thrombophilia screening in pregnant women with severe intra-uterine growth restricted babies.

Interventions

BIOLOGICALthrombophilia screening

In the IUGR group systematic thrombophilia screening had already been performed.

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Women over 18 years old * Pregnant women * IUGR defined by an EFW \<3rd centile * IUGR before 25 GW

Exclusion criteria

* none

Design outcomes

Primary

Measure	Time frame
Rate of positive's thrombophilia screening	5 years

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026